Posted by Michael Wonder on 27 Jan 2022
COVID-19 vaccine weekly safety report (27 January 2022)
27 January 2022 - To 23 January 2022, the TGA has received 431 reports which have been assessed as likely to be myocarditis from about 31.6 million doses of Comirnaty (Pfizer) and 46 reports which have been assessed as likely to be myocarditis from about 2.7 million doses of Spikevax (Moderna).
No new cases of vaccine-related thrombosis with thrombocytopenia syndrome related have been reported since 16 December last year.
